Cerebral Edema in Traumatic Brain Injury: Pathophysiology and Prospective Therapeutic Targets.

Traumatic brain injury is a heterogeneous disorder resulting from an external force applied to the head. The development of cerebral edema plays a central role in the evolution of injury following brain trauma and is closely associated with neurologic outcomes. Recent advances in the understanding of the molecular and cellular pathways contributing to the posttraumatic development of cerebral edema have led to the identification of multiple prospective therapeutic targets. The authors summarize the pathogenic mechanisms underlying cerebral edema and highlight the molecular pathways that may be therapeutically targeted to mitigate cerebral edema and associated sequelae following traumatic brain injury.

[1]  I. Klatzo Pathophysiological aspects of brain edema , 2004, Acta Neuropathologica.

[2]  K. Fountas,et al.  AQP4 tag single nucleotide polymorphisms in patients with traumatic brain injury. , 2014, Journal of neurotrauma.

[3]  J. Pickard,et al.  Continuous monitoring of the Monro-Kellie doctrine: is it possible? , 2012, Journal of neurotrauma.

[4]  U. Dirnagl,et al.  Sulfonylureas Improve Outcome in Patients With Type 2 Diabetes and Acute Ischemic Stroke , 2007, Stroke.

[5]  K. Kiening,et al.  Glibenclamide reduces secondary brain damage after experimental traumatic brain injury , 2014, Neuroscience.

[6]  P. Couraud,et al.  Methamphetamine Disrupts Blood–Brain Barrier Function by Induction of Oxidative Stress in Brain Endothelial Cells , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  J. Simard,et al.  Sulfonylurea receptor 1 in central nervous system injury: a focused review , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  B. MacVicar,et al.  The Cellular Mechanisms of Neuronal Swelling Underlying Cytotoxic Edema , 2015, Cell.

[9]  G. Rosenberg Matrix metalloproteinases in neuroinflammation , 2002, Glia.

[10]  R. Deane,et al.  Protein S controls hypoxic/ischemic blood-brain barrier disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor. , 2010, Blood.

[11]  C. Bennett,et al.  Neurogenic inflammation is associated with development of edema and functional deficits following traumatic brain injury in rats , 2004, Neuropeptides.

[12]  Geoffrey T Manley,et al.  Sevenfold-reduced osmotic water permeability in primary astrocyte cultures from AQP-4-deficient mice, measured by a fluorescence quenching method. , 2004, American journal of physiology. Cell physiology.

[13]  S. Moreno,et al.  Immunolocalization of peroxisome proliferator-activated receptors and retinoid x receptors in the adult rat CNS , 2004, Neuroscience.

[14]  J. Yi,et al.  PPARγ agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms , 2008, Brain Research.

[15]  Berislav V. Zlokovic,et al.  Apolipoprotein E controls cerebrovascular integrity via cyclophilin A , 2012, Nature.

[16]  B. Zlokovic,et al.  The Pericyte: A Forgotten Cell Type with Important Implications for Alzheimer's Disease? , 2014, Brain pathology.

[17]  J. Simard,et al.  Functional Coupling between Sulfonylurea Receptor Type 1 and a Nonselective Cation Channel in Reactive Astrocytes from Adult Rat Brain , 2003, The Journal of Neuroscience.

[18]  J. Simard,et al.  Cell Swelling and a Nonselective Cation Channel Regulated by Internal Ca2+ and ATP in Native Reactive Astrocytes from Adult Rat Brain , 2001, The Journal of Neuroscience.

[19]  X. Chen,et al.  Fenofibrate, a peroxisome proliferator-activated receptor α agonist, exerts neuroprotective effects in traumatic brain injury , 2005, Neuroscience Letters.

[20]  D. Kondziolka,et al.  The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline , 2009, Journal of Neuro-Oncology.

[21]  D. Stewart,et al.  Pathology and new players in the pathogenesis of brain edema , 2009, Acta Neuropathologica.

[22]  J. Simard,et al.  Molecular mechanisms of microvascular failure in central nervous system injury--synergistic roles of NKCC1 and SUR1/TRPM4. , 2010, Journal of neurosurgery.

[23]  A. Shetty,et al.  Blood brain barrier dysfunction and delayed neurological deficits in mild traumatic brain injury induced by blast shock waves , 2014, Front. Cell. Neurosci..

[24]  Grant Bochicchio,et al.  Key role of sulfonylurea receptor 1 in progressive secondary hemorrhage after brain contusion. , 2009, Journal of neurotrauma.

[25]  Jens P Dreier,et al.  Lasting Blood-Brain Barrier Disruption Induces Epileptic Focus in the Rat Somatosensory Cortex , 2004, The Journal of Neuroscience.

[26]  G. Rosenberg,et al.  Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia. , 2007, Neurosurgical focus.

[27]  N. Stocchetti,et al.  Time course of intracranial hypertension after traumatic brain injury. , 2007, Journal of neurotrauma.

[28]  R. Vink,et al.  Mechanisms of cerebral edema in traumatic brain injury: therapeutic developments , 2010, Current opinion in neurology.

[29]  K. Monson,et al.  Distribution of Blood–Brain Barrier Disruption in Primary Blast Injury , 2013, Annals of Biomedical Engineering.

[30]  K. Lu,et al.  NKCC1-mediated traumatic brain injury-induced brain edema and neuron death via Raf/MEK/MAPK cascade , 2008, Critical care medicine.

[31]  G. Manley,et al.  Role of water channels in fluid transport studied by phenotype analysis of aquaporin knockout mice , 2000, Experimental physiology.

[32]  T. Kawase,et al.  Quantitative analyses of matrix metalloproteinase activity after traumatic brain injury in adult rats , 2009, Brain Research.

[33]  Ø. Skare,et al.  Critical role of aquaporin-4 (AQP4) in astrocytic Ca2+ signaling events elicited by cerebral edema , 2010, Proceedings of the National Academy of Sciences.

[34]  S. Ansari,et al.  Role of vasopressin and its antagonism in stroke related edema , 2014, Journal of neuroscience research.

[35]  Kevin M. Curtis,et al.  Na‐K‐Cl cotransporter‐1 in the mechanism of cell swelling in cultured astrocytes after fluid percussion injury , 2011, Journal of neurochemistry.

[36]  Berislav V. Zlokovic,et al.  Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging , 2010, Neuron.

[37]  A. Fukuda,et al.  Development and regulation of chloride homeostasis in the central nervous system , 2015, Front. Cell. Neurosci..

[38]  O. Tasaki,et al.  Delayed Progression of Edema Formation Around a Hematoma Expressing High Levels of VEGF and MMP-9 in a Patient With Traumatic Brain Injury: Case Report , 2013, Neurologia medico-chirurgica.

[39]  Odette A. Harris,et al.  Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition , 2016, Neurosurgery.

[40]  R. Dempsey,et al.  Inhibition of Na+–K+–Cl− cotransporter during focal cerebral ischemia decreases edema and neuronal damage , 2003, Brain Research.

[41]  Kirsten M. Lynch,et al.  Vasopressin amplifies the production of proinflammatory mediators in traumatic brain injury. , 2010, Journal of neurotrauma.

[42]  R. Vink,et al.  A substance P antagonist improves outcome when administered 4h after onset of ischaemic stroke , 2011, Brain Research.

[43]  N. Plesnila,et al.  Effect of small molecule vasopressin V1a and V2 receptor antagonists on brain edema formation and secondary brain damage following traumatic brain injury in mice. , 2015, Journal of neurotrauma.

[44]  M. Papadopoulos,et al.  Aquaporins: important but elusive drug targets , 2014, Nature Reviews Drug Discovery.

[45]  J. Duncan,et al.  Early neutrophilic expression of vascular endothelial growth factor after traumatic brain injury , 2003, Neuroscience.

[46]  J. Simard,et al.  Hemorrhagic transformation of ischemic stroke in diabetics on sulfonylureas , 2012, Annals of neurology.

[47]  P. Sandercock,et al.  Corticosteroids for acute ischaemic stroke. , 2011, The Cochrane database of systematic reviews.

[48]  M. Fini,et al.  Role for Matrix Metalloproteinase 9 after Focal Cerebral Ischemia: Effects of Gene Knockout and Enzyme Inhibition with BB-94 , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[49]  G. Manley,et al.  Aquaporin‐4 facilitates reabsorption of excess fluid in vasogenic brain edema , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[50]  E. Hansson,et al.  Astrocyte–endothelial interactions at the blood–brain barrier , 2006, Nature Reviews Neuroscience.

[51]  Peter Bragge,et al.  Early management of severe traumatic brain injury , 2012, The Lancet.

[52]  L. Pitts,et al.  Breakdown of the blood-brain barrier after fluid percussive brain injury in the rat. Part 1: Distribution and time course of protein extravasation. , 1992, Journal of neurotrauma.

[53]  J. Rafols,et al.  Pericyte migration from the vascular wall in response to traumatic brain injury. , 2000, Microvascular research.

[54]  B. Zlokovic,et al.  Central nervous system pericytes in health and disease , 2011, Nature Neuroscience.

[55]  H. Young,et al.  Selective vasopressin-1a receptor antagonist prevents brain edema, reduces astrocytic cell swelling and GFAP, V1aR and AQP4 expression after focal traumatic brain injury , 2014, Brain Research.

[56]  Jesse D. Sengillo,et al.  Blood–spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice , 2014, Proceedings of the National Academy of Sciences.

[57]  R. Vink,et al.  Substance P antagonists as a therapeutic approach to improving outcome following traumatic brain injury , 2011, Neurotherapeutics.

[58]  J. Szmydynger-Chodobska,et al.  Blood–Brain Barrier Pathophysiology in Traumatic Brain Injury , 2011, Translational Stroke Research.

[59]  Q. Tu,et al.  NADPH oxidase mediates the expression of MMP-9 in cerebral tissue after ischemia–reperfusion damage , 2014, Neurological research.

[60]  J. Rafols,et al.  Differential expression of capillary VEGF isoforms following traumatic brain injury , 2007, Neurological research.

[61]  Guo-yi Gao,et al.  MMP-9 inhibitor SB-3CT attenuates behavioral impairments and hippocampal loss after traumatic brain injury in rat. , 2014, Journal of neurotrauma.

[62]  R. Vink,et al.  Substance P immunoreactivity increases following human traumatic brain injury. , 2010, Acta neurochirurgica. Supplement.

[63]  S. Yuan,et al.  Myosin light chain kinase in microvascular endothelial barrier function. , 2010, Cardiovascular research.

[64]  K. Furie,et al.  Glyburide is Associated with Attenuated Vasogenic Edema in Stroke Patients , 2013, Neurocritical Care.

[65]  J. Simard,et al.  Pilot Study of Intravenous Glyburide in Patients With a Large Ischemic Stroke , 2014, Stroke.

[66]  A. Marmarou,et al.  Bolus tracer delivery measured by MRI confirms edema without blood-brain barrier permeability in diffuse traumatic brain injury. , 2006, Acta neurochirurgica. Supplement.

[67]  R. Vink,et al.  A substance P antagonist reduces axonal injury and improves neurologic outcome when administered up to 12 hours after traumatic brain injury. , 2011, Journal of neurotrauma.

[68]  G. E. Vates,et al.  A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β , 2012, Science Translational Medicine.

[69]  Frank J. Yuk,et al.  Selective vulnerability of the cerebral vasculature to blast injury in a rat model of mild traumatic brain injury , 2014, Acta neuropathologica communications.

[70]  R. Mccoll,et al.  Cytotoxic and vasogenic cerebral oedema in traumatic brain injury: Assessment with FLAIR and DWI imaging , 2014, Brain injury.

[71]  G. Manley,et al.  Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke , 2000, Nature Medicine.

[72]  Guy C. Brown,et al.  Inflammatory Neurodegeneration and Mechanisms of Microglial Killing of Neurons , 2010, Molecular Neurobiology.

[73]  Donald W. Miller,et al.  Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood-brain barrier compromise. , 2005, Alcoholism, clinical and experimental research.

[74]  K. Engelhard,et al.  Inhibition of Proteasomal Glucocorticoid Receptor Degradation Restores Dexamethasone-Mediated Stabilization of the Blood–Brain Barrier After Traumatic Brain Injury* , 2013, Critical care medicine.

[75]  W. Su,et al.  Changes and effects of plasma arginine vasopressin in traumatic brain injury , 2008, Journal of endocrinological investigation.

[76]  E. Nagelhus,et al.  Aquaporin-4 in the central nervous system: Cellular and subcellular distribution and coexpression with KIR4.1 , 2004, Neuroscience.

[77]  N. Chandra,et al.  Induction of oxidative and nitrosative damage leads to cerebrovascular inflammation in an animal model of mild traumatic brain injury induced by primary blast. , 2013, Free radical biology & medicine.

[78]  Wade R. Smith,et al.  Peroxisome Proliferator-Activated Receptors: “Key” Regulators of Neuroinflammation after Traumatic Brain Injury , 2008, PPAR research.

[79]  W. Sibley,et al.  Corticosteroids or ACTH for acute exacerbations in multiple sclerosis. , 2000, The Cochrane database of systematic reviews.

[80]  A. Marmarou,et al.  Pathophysiology of traumatic brain edema: current concepts. , 2003, Acta neurochirurgica. Supplement.

[81]  B. Zlokovic The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders , 2008, Neuron.

[82]  G. Bing,et al.  Pioglitazone attenuates mitochondrial dysfunction, cognitive impairment, cortical tissue loss, and inflammation following traumatic brain injury , 2011, Experimental Neurology.

[83]  Anthony Marmarou,et al.  Predominance of cellular edema in traumatic brain swelling in patients with severe head injuries. , 2006, Journal of neurosurgery.

[84]  Heiko J. Luhmann,et al.  Traumatic brain injury results in rapid pericyte loss followed by reactive pericytosis in the cerebral cortex , 2015, Scientific Reports.

[85]  Anthony Marmarou,et al.  A review of progress in understanding the pathophysiology and treatment of brain edema. , 2007, Neurosurgical focus.

[86]  E. Shohami,et al.  Vascular Endothelial Growth Factor Increases Neurogenesis after Traumatic Brain Injury , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[87]  H. Luhmann,et al.  Inhibition of myosin light chain kinase reduces brain edema formation after traumatic brain injury , 2010, Journal of neurochemistry.

[88]  A. Biegon,et al.  Novel approach to the role of NMDA receptors in traumatic brain injury. , 2014, CNS & neurological disorders drug targets.

[89]  A. Marmarou,et al.  Secondary ischemia impairing the restoration of ion homeostasis following traumatic brain injury. , 2005, Journal of neurosurgery.

[90]  Pamela S. Jones,et al.  Molecular mechanisms of ischemic cerebral edema: role of electroneutral ion transport. , 2009, Physiology.

[91]  B. N. Tomlinson,et al.  Selective Inhibition of Matrix Metalloproteinase-9 Attenuates Secondary Damage Resulting from Severe Traumatic Brain Injury , 2013, PloS one.

[92]  Miikka Vikkula,et al.  Cerebrovascular disorders: molecular insights and therapeutic opportunities , 2011, Nature Neuroscience.

[93]  D. Stewart,et al.  Review: Molecular pathogenesis of blood–brain barrier breakdown in acute brain injury , 2011, Neuropathology and applied neurobiology.

[94]  C. Förster,et al.  Glucocorticoids and endothelial cell barrier function , 2013, Cell and Tissue Research.

[95]  P. Hof,et al.  Vascular and Inflammatory Factors in the Pathophysiology of Blast-Induced Brain Injury , 2015, Front. Neurol..

[96]  G. Manley,et al.  Mildly Reduced Brain Swelling and Improved Neurological Outcome in Aquaporin-4 Knockout Mice following Controlled Cortical Impact Brain Injury. , 2015, Journal of neurotrauma.

[97]  A. Obenaus,et al.  Posttraumatic Reduction of Edema with Aquaporin-4 RNA Interference Improves Acute and Chronic Functional Recovery , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[98]  G. Manley,et al.  Aquaporins: role in cerebral edema and brain water balance. , 2007, Progress in brain research.

[99]  Michael Chopp,et al.  Animal models of traumatic brain injury , 2013, Nature Reviews Neuroscience.

[100]  P. Kochanek,et al.  Pharmacotherapy of Traumatic Brain Injury: State of the Science and the Road Forward: Report of the Department of Defense Neurotrauma Pharmacology Workgroup , 2014 .

[101]  A. Maas,et al.  Traumatic intracranial hypertension. , 2014, The New England journal of medicine.

[102]  B. Zlokovic Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders , 2011, Nature Reviews Neuroscience.

[103]  N. van Bruggen,et al.  VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. , 1999, The Journal of clinical investigation.

[104]  G. Manley,et al.  Aquaporin-1 deletion reduces osmotic water permeability and cerebrospinal fluid production. , 2003, Acta neurochirurgica. Supplement.

[105]  J. Rafols,et al.  Hypoxia-inducible factor-1α signaling in aquaporin upregulation after traumatic brain injury , 2009, Neuroscience Letters.

[106]  J. Langlois,et al.  The Epidemiology and Impact of Traumatic Brain Injury: A Brief Overview , 2006, The Journal of head trauma rehabilitation.

[107]  M. Wald,et al.  Traumatic brain injury in the United States; emergency department visits, hospitalizations, and deaths, 2002-2006 , 2010 .

[108]  K. Mori,et al.  Temporal profile of changes in brain tissue extracellular space and extracellular ion (Na(+), K(+)) concentrations after cerebral ischemia and the effects of mild cerebral hypothermia. , 2002, Journal of neurotrauma.

[109]  Geoffrey T Manley,et al.  Traumatic brain injury: an international knowledge-based approach. , 2013, JAMA.

[110]  S. Meuth,et al.  Glucocorticoid Insensitivity at the Hypoxic Blood–Brain Barrier Can Be Reversed by Inhibition of the Proteasome , 2011, Stroke.

[111]  H. Yonas,et al.  ELEVATION OF MATRIX METALLOPROTEINASES 3 AND 9 IN CEREBROSPINAL FLUID AND BLOOD IN PATIENTS WITH SEVERE TRAUMATIC BRAIN INJURY , 2009, Neurosurgery.

[112]  A. Dray,et al.  Kinins and kinin receptors in the nervous system , 1995, Neurochemistry International.

[113]  B. Palmier,et al.  Neurological recovery-promoting, anti-inflammatory, and anti-oxidative effects afforded by fenofibrate, a PPAR alpha agonist, in traumatic brain injury. , 2007, Journal of neurotrauma.

[114]  R. Bullock,et al.  Moderate and severe traumatic brain injury in adults , 2008, The Lancet Neurology.

[115]  B. N. Tomlinson,et al.  Water-Soluble MMP-9 Inhibitor Reduces Lesion Volume after Severe Traumatic Brain Injury. , 2015, ACS chemical neuroscience.

[116]  H. Luhmann,et al.  Inhibition of the myosin light chain kinase prevents hypoxia‐induced blood–brain barrier disruption , 2007, Journal of neurochemistry.

[117]  V. Perry,et al.  Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood–brain barrier breakdown in vivo , 1998, Neuroscience.

[118]  David W Wright,et al.  Position statement: definition of traumatic brain injury. , 2010, Archives of physical medicine and rehabilitation.

[119]  B. Masel,et al.  Traumatic brain injury: a disease process, not an event. , 2010, Journal of neurotrauma.

[120]  T. Kondoh,et al.  Effect of VEGF receptor antagonist (VGA1155) on brain edema in the rat cold injury model. , 2007, The Kobe journal of medical sciences.

[121]  P. Alderson,et al.  Corticosteroids for acute traumatic brain injury. , 2005, The Cochrane database of systematic reviews.

[122]  Odette A. Harris,et al.  Guidelines for the management of severe traumatic brain injury. XV. Steroids. , 2007, Journal of neurotrauma.

[123]  L. Belayev,et al.  Inhibition of Myosin light-chain kinase attenuates cerebral edema after traumatic brain injury in postnatal mice. , 2013, Journal of neurotrauma.

[124]  A. Marmarou,et al.  The permissive nature of blood brain barrier (BBB) opening in edema formation following traumatic brain injury. , 2000, Acta neurochirurgica. Supplement.

[125]  C. Baumgarten,et al.  Real-time monitoring of changes in brain extracellular sodium and potassium concentrations and intracranial pressure after selective vasopressin-1a receptor inhibition following focal traumatic brain injury in rats. , 2014, Journal of neurotrauma.

[126]  R. McCarron,et al.  Increase in blood–brain barrier permeability, oxidative stress, and activated microglia in a rat model of blast‐induced traumatic brain injury , 2010, Journal of neuroscience research.

[127]  J. Simard,et al.  Newly expressed SUR1-regulated NCCa-ATP channel mediates cerebral edema after ischemic stroke , 2006, Nature Medicine.

[128]  R. Bordet,et al.  Peroxisome Proliferator-Activated Receptor-α Activation Protects Brain Capillary Endothelial Cells from Oxygen-Glucose Deprivation-Induced Hyperpermeability in the Blood-Brain Barrier , 2009 .

[129]  H. Nakase,et al.  Vascular Endothelial Growth Factor Antagonist Reduces Brain Edema Formation and Venous Infarction , 2005, Stroke.

[130]  S. Thal,et al.  The blood-brain barrier as a target in traumatic brain injury treatment. , 2014, Archives of medical research.

[131]  S. Wisniewski,et al.  Vascular Endothelial Growth Factor Is Increased in Cerebrospinal Fluid after Traumatic Brain Injury in Infants and Children , 2004, Neurosurgery.

[132]  G. Manley,et al.  The role of aquaporin-4 in cerebral water transport and edema. , 2007, Neurosurgical focus.

[133]  Jesse D. Sengillo,et al.  Blood–spinal cord barrier pericyte reductions contribute to increased capillary permeability , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[134]  C. Löhr,et al.  Localization of myosin II regulatory light chain in the cerebral vasculature. , 2008, Acta histochemica.

[135]  J. Rafols,et al.  Neuronal damage and functional deficits are ameliorated by inhibition of aquaporin and HIF1α after traumatic brain injury (TBI) , 2012, Journal of the Neurological Sciences.

[136]  D. Kintner,et al.  Na+-Dependent Chloride Transporter (NKCC1)-Null Mice Exhibit Less Gray and White Matter Damage after Focal Cerebral Ischemia , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[137]  K. Lu,et al.  Inhibition of the Na+ -K+ -2Cl- -cotransporter in choroid plexus attenuates traumatic brain injury-induced brain edema and neuronal damage. , 2006, European journal of pharmacology.

[138]  P. Carmeliet,et al.  Molecular mechanisms and clinical applications of angiogenesis , 2011, Nature.

[139]  R. Vink,et al.  Substance P is Associated with the Development of Brain Edema and Functional Deficits after Traumatic Brain Injury , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[140]  J. Marc Simard,et al.  Novel Treatment Targets for Cerebral Edema , 2011, Neurotherapeutics.

[141]  B. Aarabi,et al.  Intracranial Pressure Dose and Outcome in Traumatic Brain Injury , 2013, Neurocritical Care.

[142]  J. Szmydynger-Chodobska,et al.  Multiple Sites of Vasopressin Synthesis in the Injured Brain , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[143]  José Luís Alves,et al.  Blood–brain barrier and traumatic brain injury , 2014, Journal of neuroscience research.